Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Extensively drug-resistant tuberculosis

Extensively drug-resistant tuberculosis

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Extensively drug-resistant tuberculosis

4 trials tracked for Extensively drug-resistant tuberculosis: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 579 citations.

4Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 2
  1. Phase 3 Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis Completed · 579 cited
  2. Phase 4 Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients Completed
  3. Phase 2 Linezolid to Treat Extensively-Drug Resistant Tuberculosis Completed
  4. Phase 2 A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.